Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Evaluation of Exhaled Nitric Oxide (NO)

This study has been completed.
National Institutes of Health (NIH)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 8, 2011
Last updated: April 1, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)